Debra BorchardtMay 16, 2023
CEO: "2023 is the most important year in Seelos' history thus far."
ketamine Archives - Green Market Report
Debra BorchardtMay 16, 2023
Adam JacksonMay 11, 2023
The company's net loss ticked down after March labor cuts.
Debra BorchardtMay 2, 2023
KETARX is an injectable ketamine formulation to treat a symptom of Parkinson's.
Adam JacksonApril 5, 2023
The company's portfolio includes several late-stage clinical assets.
Adam JacksonMarch 6, 2023The psychedelic biopharma shop laid off 30% of its employees.
Debra BorchardtFebruary 13, 2023
Seelos expects to launch an expanded access program for the treatment later this quarter.
Adam JacksonFebruary 2, 2023
Previous studies have suggested ketamine has the potential to promote synaptic repair in Rett syndrome.
Adam JacksonJanuary 6, 2023Atai plans to continue working with its compound despite the setback.
Dave HodesOctober 31, 2022
Novel treatments are required. That’s where psychedelics come in.
Dave HodesOctober 24, 2022More groups are researching the effect of psychedelics on TBI.
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.
